Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02652000

Enrollment

Registered

2016-01-11

Start date

2009-10-31

Completion date

2016-12-31

Last updated

2016-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Prostate

Brief summary

Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer

Detailed description

Retrospective Evaluation of Quality of life data collected on men who underwent iodine seed brachytherapy at the University Hospital Zurich

Interventions

OTHERNo intervention in this retrospective study

No Intervention in this retrospective Analysis.

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

48 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Male \> 18 years of age * iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Exclusion criteria

* No iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Design outcomes

Primary

Measure	Time frame	Description
CTCAE v4.03ff Grade 1-4 Sexual/Reproductive Function	5 years (2009-2014)	Scale

Secondary

Measure	Time frame	Description
CTCAE v4.03ff Grade 1-4 Gastrointestinal	5 years (2009-2014)	Scale
CTCAE v4.03ff Grade 1-4 Renal/Genitourinary	5 years (2009-2014)	Scale
International Prostate Symptom Score (IPSS)	5 years (2009-2014)	Scale
International Index of erectile function, five items (IIEF-5)	5 years (2009-2014)	Scale

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026